AHV-21883-63307
2 vaccinations
6 coded responses
15 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 480 / MI
- Registered
- 2021-01-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Dose 1 — Pfizer-BioNTech
-
2021-01-11
Registered in v-safe
-
2021-01-11
Dose 2 — Pfizer-BioNTech
-
2021-01-11
Survey response — day 0, dose 2MedDRA: Heart rate increased — Feeling: Good · HeadacheFree text: Elevated heart rateMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-01-13
Survey response — days 1–6 daily, dose 2MedDRA: Hypoaesthesia, Lymphadenopathy — Feeling: Fair · Site: Pain · Chills, Fatigue or tirednessFree text: Swollen lymph nodes, numbnessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-14
Survey response — days 1–6 daily, dose 2MedDRA: Hypoaesthesia — Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Numbness on left side of bodyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-14
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-01-15
- 2021-01-17
-
2021-01-18
Survey response — day 7, dose 2MedDRA: Dizziness — Feeling: Fair · HeadacheFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-25
Survey response — day 14, dose 2MedDRA: Hypogeusia — Feeling: FairFree text: Diminished sense of taste that has been present since second doseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-03
- 2021-02-10
- 2021-02-15
- 2021-02-24
- 2021-03-09
- 2021-04-12
- 2021-07-12
-
2022-01-11
Survey response — 12 months, dose 2MedDRA: Breakthrough COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Breakthrough Covid in SeptemberMedDRA releases: 2024-11 · check-in free text available
-
2022-01-11
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-01-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-11 | Pfizer-BioNTech |
Call center
2 call center cases
2 unsuccessful
Free text
Release 1 — day 0, dose 2
Systemic reaction (other): Elevated heart rate
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen lymph nodes, numbness
Systemic reaction (other): Numbness on left side of body
Release 2 — day 7, dose 2
Systemic reaction (other): Dizziness
Release 2 — day 14, dose 2
Symptoms: Diminished sense of taste that has been present since second dose
Release 10 — 12 months, dose 2
Symptoms: Breakthrough Covid in September
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Breakthrough COVID-19 | · | · | ✓ |
| SD | Hypogeusia | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Heart rate increased | ✓ | ✓ | ✓ |
| SRO | Hypoaesthesia | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release